Harvey R. Colten

Harvey R. Colten

Keine laufenden Positionen mehr

85 Jahre
Consumer Services
Health Technology
Health Services

Profil

Harvey R.
Colten
has been a Director of Immtech International, Inc. since October 30, 2000.
He is Vice President and Senior Associate Dean for Academic Affairs at Columbia University Health Sciences Division and College of Physicians and Surgeons.
He was Chief Medical Officer of iMetrikus, Inc. from 2000 to 2002 and Dean of the Medical School and Vice President for Medical Affairs at Northwestern University from 1997 to 2000.
He was a Researcher at the National Institutes of Health from 1965 to 1970.
He is a Member of the American Society for Clinical Investigation, the Society for Pediatric Research, the Association of American Physicians, the American Pediatric Society, the American Association of Immunologists and the American Society for Biochemistry and Molecular Biology.
He is a Fellow of the American Association for the Advancement of Science, the American Academy of Allergy and Immunology and the American Academy of Pediatrics.
He received a BA from Cornell University in 1959, an MD from Western Reserve University in 1963 and an MA from Harvard in 1978.

Ehemalige bekannte Positionen von Harvey R. Colten

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 24.05.2007
Technik-/Wissenschafts-/F&E-Leiter 24.05.2007
Sehen Sie sich die Erfahrung von Harvey R. Colten im Detail an

Ausbildung von Harvey R. Colten

Cornell University Undergraduate Degree
Case Western Reserve University Doctorate Degree
Harvard University Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Harvey R. Colten im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

5

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen2

Health Technology

Health Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Harvey R. Colten